A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy.
Phase of Trial: Phase I
Latest Information Update: 24 May 2017
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics; Registrational
- Sponsors Supernus Pharmaceuticals
- 06 Jun 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 06 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jan 2011 Additional lead trial investigator (Jennifer Stocks) identified as reported by Clinical Trials Registry - India record.